An unknown buyer acquired a 5% stake in Immunocore Holdings plc (NasdaqGS:IMCR) from Malin Corporation plc (ISE:MLC) for approximately €150 million on December 7, 2022. The proceeds of sale will used to return approximately €140 million to Malin's shareholders and remaining cash balance will be used to fund the Malin's operations, including the possible investment of additional capital into Malin's existing assets.

An unknown buyer completed the acquisition of a 5% stake in Immunocore Holdings plc (NasdaqGS:IMCR) from Malin Corporation plc (ISE:MLC) on December 7, 2022.